According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.
According to a new market report published by Persistence Market Research “Global Market Study on Microfluidic Devices: Asia to Witness Highest Growth by 2019” the global microfluidic device market was valued at USD 1,531.2 million in 2013 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 5,246.4 million in 2019.
Globally, the microfluidic device market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems.
To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/2995
In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array.
Different materials such as glass, silicon, polymer metal and ceramics, are used to manufacture microfluidic devices. The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.
In North America, rising aging population, increasing health awareness, rising chronic and lifestyle diseases, technological developments for various home use applications, and proper insurance coverage are driving the use of microfluidic devices in the market. Usage of microfluidic technology in North America is high compared to other regions of the world due to its early adoption and multiple applications in different industries.
Request for Customization Here @ https://www.persistencemarketresearch.com/request-customization/2995
In Europe, the microfluidic device market is driven by rising diagnostic requirements due to increasing lifestyle associated diseases, aging population and improving healthcare infrastructure. On the other hand, increasing healthcare costs has shifted the focus of healthcare from hospitals to home, which would increase the use of microfluidic devices in the region.
However, Asia is becoming one of the most attractive markets for medical device companies. The growth for microfluidic devices is much faster than developed countries due to widening health insurance penetration and up-gradation of health care systems. Asia is one of the producers of generic drugs, which require microfluidic devices for toxicity testing of drugs.
For In-Depth Competitive Analysis, Buy now @ https://www.persistencemarketresearch.com/checkout/2995
Some of the major players in the microfluidic device market:
- Roche Diagnostics.
- Abbott Laboratories.
- Siemens Healthcare.
- Agilent Technologies.
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation.
- Johnson & Johnson.
- Other.
More about the Life Sciences & Transformational Health –
Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.
The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.
Get Similar Articles
Aesthetic Lasers And Energy Devices Market -
Aesthetic Lasers and Energy Devices Market Segmented Hair Removal, Scar Removal and Skin Resurfacing, Skin Rejuvenation, Skin Tightening by Application and Laser Resurfacing Devices, Body Contouring Devices, and Aesthetic Ophthalmology Devices in Product and Laser-based Technology, Light-based Technology, and Energy-based Technology in Technology For More Inforamtion
Cannabidiol Supplements Market -
The major key players operating in the cannabidiol supplements market are Greenwich Biosciences, Inc., Endoca, C V Sciences, Isodiol International, Global cannabinoids, Folium Biosciences, HempMeds, Stock CBD supplements, Medical Marijuana, Inc, Elixinol, and Pharmahemp D.o.o. For More Information
About us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact us:
305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. +1-646-568-7751
E-mail id– sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
